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ABSTRACT
Objective: To assess, by Rankin scale, the functional disability of patients who had a malignant middle cerebral artery (MCA) ischemic stroke, 
who underwent decompressive craniotomy (DC) within the first 30 days. Methods: A cross-sectional study in a University hospital. Between 
June 2007 and December 2014, we retrospectively analyzed the records of all patients submitted to DC due to a malignant MCA infarction. 
The mortality rate was defined during the hospitalization period. The modified outcome Rankin score (mRS) was measured 30 days after the 
procedure, for stratification of the quality of life. Results: The DC mortality rate was 30% (95% CI 14.5 to 51.9) for the 20 patients reported. 
The mRS 30 days postoperatively was ≥ 4 [3.3 to 6] for all patients thereafter. Conclusion: DC is to be considered a real alternative for the 
treatment of patients with a malignant ischemic MCA infarction.
Keywords: craniotomy; cerebral infarction; intracranial hypertension.
RESUMO
Objetivo: Avaliar a capacidade funcional de pacientes com acidente vascular cerebral isquêmico no território da artéria cerebral média (ACM) 
submetidos à craniotomia descompressiva (CD) no período de 30 dias pela escala de Rankin. Métodos: Estudo transversal em um hospital 
universitário. Entre junho de 2007 e dezembro de 2014, analisados retrospectivamente os registros de todos os pacientes submetidos a CD 
devido a enfarte maligno na ACM. A taxa de mortalidade foi definida durante o período de internação. O resultado da estratificação da qualidade 
de vida foi através da escala Rankin modificado (mRS) mensurado em 30 dias após o procedimento. Resultados: A taxa de mortalidade CD 
foi de 30% (IC 95% 14,5-51,9) para os 20 pacientes relatados. A mRS 30 dias de pós-operatório foi => 4 [3,3-6] para todos os pacientes. 
Conclusão: CD deve  ser considerada uma alternativa real para o tratamento de pacientes com enfarte isquêmico no território da ACM.
Palavras-chave: craniotomia; infarto cerebral; hipertensão intracraniana.
A decompressive craniotomy (DC) has been a therapeutic 
option for an infarction of the middle cerebral artery (MCA) 
region. The goal of the surgical treatment is the reduction of 
the intracranial hypertension. The procedure is based on a 
fronto-parieto-temporal craniotomy, ipsilateral to the lesion, 
followed by plastic reconstruction of the dura mater, allowing 
immediate decompression of the brain1,2,3,4,5.
Some complications, such as infection of the surgical area, 
temporal muscle hematoma with cerebral compression, intrace-
rebral hemorrhage, or worsening of the neurological condition 
may follow DC2,3,4. In order to clearly define the indication for the 
surgical treatment and to decrease complications derived from 
DC in a university hospital in southern Brazil, a specific proto-
col for DC in the treatment of intracranial hypertension derived 
from ischemia of the MCA region has been implemented since 
2007, in conjunction with the neurology department. Even 
though studies have demonstrated the efficacy of DC in patients 
presenting with malignant MCA infarction5,6,7,8,9,10, some resis-
tance to its application still exists, particularly regarding the 
functionality of the patients who survive the acute event.
The goals of the present study were to assess the mor-
tality rates from the use of DC in the treatment of patients 
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with intracranial hypertension due to an ischemic infarction 
of the MCA region. A secondary objective was to assess the 
quality of life of the patients discharged from hospital after 
the procedure, by means of the modified Rankin scale (mRS) 
score, 30 days after discharge from the hospital.
METHODS
A retrospective cohort study was performed in a single 
center setting, in a public teaching hospital. All patients sub-
jected to DC for the treatment of intracranial hypertension 
in the MCA region, between June 2007 and December 2014, 
were included. Data were extracted from electronic records, 
including general patient characteristics, clinical and surgi-
cal variables: time elapsed from the ictus to admission in the 
Hospital de Clínicas de Porto Alegre emergency unit, National 
Institutes of Health Stroke Scale (NIHSS) score upon admis-
sion, time elapsed between the first neurosurgery evaluation 
and the therapeutic decision to proceed with DC, interval in 
hours between the primary event and the surgery, clinical 
worsening after the first neurosurgery evaluation, number 
of CT scans necessary for the surgical decision, time inter-
val between the last CT and the DC, mRS score at the time 
of hospital discharge and after 30 days, the outcome after DC 
(discharge/death); and the in-hospital time interval.
The sample consisted of 20 patients, corresponding to 
the total number of patients submitted to DC in the referred 
period. For the surgical indication, the institutional protocol 
is detailed in Table 1.
Surgical technique
The following were the stages of the surgery. Patient was 
positioned in dorsal decubitus. Head pin-fixed, elevated 60º 
and rotated approximately 90º, to make it parallel to the floor. 
Elevation of the ipsilateral shoulder. Upper and lower limbs 
were stretched out along the body. Surgical asepsis was 
done with chlorhexidine, followed by alcohol chlorhexidine. 
Demarcation of the surgical incision with a dermographic 
pen, in a curved line, extending from the frontal region 
(about 1 to 2 cm away from the midline), involving the pari-
etal region and ending at the base of the ipsilateral temporal 
bone. Placement of surgical towels. Skin incision, following 
the previous delimited marking. Hemostasis and divulsion of 
the planes (some authors advocate the use of a single plane), 
with preservation of the ipsilateral temporal artery, as well 
as the frontal branch of the facial nerve. Identification and 
incision the temporal muscle fascia: opening in a single 
plane or not. Detachment of the temporal muscle from the 
bone plate and traction. Bone wax hemostasis. Craniotomy, 
preferably with a craniotome, with previous demarcation of 
the main points, such as the inion, with preservation of the 
frontal sinuses. Detachment of the bone plate. Hemostasis 
of the bone edges with bone wax. Dural opening in arc, with 
Table 1. Institutional decompressive craniotomy protocol.
Protocol inclusion criteria
National Institutes of Health Stroke Scale (NIHSS) > 15, clinical 
evidence of MCA extensive infarction (complete hemiparesis 
contralateral to the lesion, homonymous hemianopsia 
contralateral to the lesion, tendency for oculocephalic deviation 
towards the lesion, language alteration, heminegligence); 
Age ≤ 60 years (in patients older than 60 years, the decision 
must be individualized);
Tomographic evidence of early hypodensity involving cortico-
subcortical topography > 50% of the MCA territory.
Protocol exclusion criteria
Other previous incapacitating diseases (skeletal muscle, 
neurologic or clinical);
Signs of severe neurological deterioration at the time of 
surgical indication (unilateral or bilateral pupil dilatation, 
with mydriasis or absence of photo-reaction, and/or signs of 
pathological extension or flexion);
Severe clinical complications;
Terminal illness;
mRS ≥ 3;
Clotting disorders;
Unavailability of the intensive care unit (ICU) beds;
Hemodynamic instability at the time of surgical indication.
Patient initial follow-up
Second CT between 6–12 hours after patient arrival, or less, in 
the case of neurological deterioration – early detection of the 
malignant evolution;
After the second CT: new CT every six to eight hours.
Indication for decompressive surgery
Any neurological deterioration in relation to the admission or 
history of neurological deterioration since the beginning of the 
symptoms;
Any tomographic worsening (extension of the infarction or 
worsening of the space-occupying effect).
Levels of evidence of the recommendations
Early DC is recommended for the treatment of MCA space 
occupying cerebral infarction in patients up to 60 years of age, 
before the manifestation of clinical or radiological signs of 
cerebral herniation, within the time span of 48 hours (evidence 
level 1, recommendation grade A - Systematic Review (with 
homogeneity) of controlled and randomized clinical trials).
The decision of DC for patients older than 60 years of age 
or after 48 hours must be individualized. (evidence level 4, 
recommendation grade C - case reports (including cohort or 
case control of lesser quality).
The independent variables studied were: age, sex, marital 
status, time elapsed between ictus and surgery, first CT and 
surgery and the score of the National Institutes of Health 
Stroke Scale (NIHSS) upon admission.
The mRS evaluates the functionality of the individual after 
a CVA (either ischemic or hemorrhagic) and it became an 
important clinical tool capable of estimating the prognosis 
and the outcome. It comprises seven items, with a score of 
zero being considered without symptoms, and a score of 6 
being death (Addendum 1).
The primary regarded outcomes were death and hospital 
discharge: surgical deaths were considered up to 30 days 
after the DC operation. For every patient, the mRS scores were 
measured: those that died scored 6; patients discharged from 
hospital within 30 days had their score measured at that time.
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the base towards the parietal lobe, or in a cruciform shape. 
Hemostasis and dural anchoring to the bone edges. Brain irri-
gation with warm saline solution. Dural opening in a cruci-
ate fashion, followed by duraplasty, preferably with aponeu-
rotic galea previously prepared or fascia lata, taken from the 
lateral vastus muscle, with continuous stitches and sealed 
with biological glue. Placement of a closed draining sys-
tem. Subcutaneous tissues and skin closing. Head dressing 
with surgical gauze, bandage and adhesive tape, with a label: 
“WITHOUT BONE FLAP”. Straight incision in the upper 
quadrant of the ipsilateral hemiabdomen. Hemostasis and 
identification of the subcutaneous tissue. Identification, 
hemostasis and detachment of the fat tissue. Identification 
of the muscular fascia. Insertion of the bone flap under the 
muscular fascia. Careful review of the hemostasis. Suture by 
planes. Simple abdominal dressing.
Statistical analysis
The data analysis was done using the Statistical Package 
for Social Sciences (SPSS) 18.0. The categorical variables 
were expressed as absolute value and percentage; the 
continuous variables as average ± standard deviation or 
median and interquartile ranges, according to data distri-
bution. The Kaplan-Meier curve was created to report the 
in-hospital mortality.
RESULTS
In the period of the study, a total of 20 patients were sub-
jected to DC for the treatment of intracranial hypertension 
due to malignant MCA ischemia. The socio-demographic 
characteristics of the patients included are shown in Table 2.
The time elapsed between the ictus and the admission 
to the emergency unit of the Hospital de Clínicas de Porto 
Alegre was an average of 13.2 ± 1.4 hours: in two patients, 
it was not possible to accurately establish the time of the pri-
mary event. Of the total of patients evaluated by neurosur-
gery, 65% needed a second evaluation due to clinical wors-
ening, when the procedure was indicated. The number of 
CTs before surgery was 2 [1.2–3], until an eventual definitive 
hypodense area was established. The time interval between 
the last CT and the surgical procedure was 7.7 [2.3–14.8] 
hours, considering the time elapsed from the neurosurgi-
cal evaluation and the availability of the operating room for 
the performance of the operation. The median mRS 30 days 
after the procedure was 4 [3.3–6] for all patients undergoing 
DC. Those who were discharged with neurological deficits 
had a mRS score 4 [3–4]. 
The clinical and surgical characteristics are shown in Table 3.
The DC mortality rate evaluated 30 days postoperatively 
(Figure) was 30% (95%CI 14.5–51.9).
Table 2. Socio-demographic characteristics of the patients 
included in the study.
Demographic variables n = 20
Age (years)* 52.7 ± 7.4
Sex (%)**  
Male 11 (55)
Female 9 (45)
Skin color (%)**  
White 15 (75)
Black 5 (25)
*Continuous variable expressed as average ± standard deviation; 
**Categorical variables expressed as n (%).
Table 3. Clinical and surgical characteristics of the patients 
included in the study.
Variables n = 20
Ictus time x admission (hours)* 13.2 ± 1.4
Hospitalization NIHSS (score)* 17.6 ± 3.2
NCI evaluation x surgery (hours)** 2.9 [1.9–4.4]
Ictus time x surgery (hours)** 28.1 [21.2–50.6]
Clinical worsening after 1st NCI evaluation (%)*** 13 (65)
Nº of CTs before surgery** 2 [1.2–3]
Time interval between surgery and last CT (hours)** 7.7 [2.3–14.8]
Rankin (30 days score)** 4 [3.3–6]
Rankin (discharge score)** 4 [3–4]
Discharge rate (%)*** 14 (70)
Death rate (%)*** 6 (30)
Hospitalization time (days)** 21.5 [9.5–34.5]
NIHSS: National Institutes of Health Stroke Scale; NCI: neurosurgery; 
CT: computerized tomography. *Continuous variable expressed as 
average ± standard deviation; **Asymmetrical variables expressed as 
median and interquartile interval; ***Categorical variables expressed 
as n (%).
Figure. Kaplan-Meier curve of in-hospital mortality of patients 
included in the study.
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DISCUSSION
To the best of our knowledge, this is the first study 
that assessed the DC outcome in malignant MCA infarc-
tion in an academic hospital in Brazil, considered a ref-
erence for the treatment of stroke patients nationwide. 
As a main finding, there was a 30% mortality rate among 
patients subjected to DC. Another Brazilian study, involv-
ing 34 patients, showed similar data, with a surgical mor-
tality rate of 26%11.
Previous studies12,13 have recommended performing DC 
for the treatment of malignant cerebral infarction in patients 
aged 60 years or less, before clinical or radiological signs of 
brain herniation, within a time frame of 48 hours. In the pres-
ent study, we had an average age of 52.7 ± 7.4 years, includ-
ing three patients over 60 years of age. The average age of 
patients in the randomized controlled trials HeADDFIRST14, 
DECIMAL9, DESTINY8 and HAMLET7 was, respectively, 54.6; 
43.4; 44.6 and 48.2 years.
Several studies have reported that age should be con-
sidered an important factor in patients to be submitted 
to the surgical procedure15,16,17. The decision for patients 
over 60 years of age must be individualized: there is great 
controversy regarding this cut-off point, as some authors 
describe benefits beyond this age-group12,15,18,19, while oth-
ers report unfavorable outcomes6,7,8,9. In the present study, 
three patients over 60 years of age were included. A Chinese 
study evaluated the effectiveness of DC in patients over 
80 years of age, concluding that DC, even in patients in this 
age group, may increase the survival rate without severe 
compromise of functionality18. In a recent American study, 
involving more than 1,600 patients, the authors reported 
the results according to age as uni- and multivariate analy-
sis, not taking into account this variable as a significant pre-
dictor of clinical outcome20.
In the present study, an average of 3,5 points in the 
mRS score was found among survivors, a value considered 
acceptable (mild to moderately severe disability), as those 
patients probably would have died without surgical treat-
ment. A recent cross-sectional and multicenter study 
aimed at identifying the opinion of more than 1,800 phy-
sicians, with clinical experience in MCA treatment, about 
what they considered an acceptable disability. The major-
ity of respondents (79.3%) considered acceptable mRS 
scores of 3 or greater21.
Individuals affected by a malignant ischemic event are 
seldom discharged without severe clinical deficits; this data 
is in accordance with a recent study of meta-analysis carried 
out in China, involving more than 700 patients, that consid-
ered an mRS of 4 a good functional result10.
In two out of the 20 patients in the sample, it was 
not possible to clearly determine the approximate time 
lapse from stroke to admission in the emergency unit of 
the hospital. In those where this information could be 
obtained, the average time was 13.2 ± 1.4 hours. Such 
data has a potential clinical significance, since the longer 
the time between the ictus, the diagnosis and the opera-
tion procedure, the smaller the chances of positive out-
comes are.
The median time between the ictus and the opera-
tion was 28.1 [21.2–50.6] hours, different from another 
Brazilian study with 34 cases that presented an average 
time of 2.05 days11. We highlight that, among the stud-
ied patients, three were submitted to the procedure late, 
due to the lack of a clear definition of the MCA territory 
hypodensity > 2/3. This was confirmed by the number of 
CTs before the operation (2.2 [1–5]), data that suggests 
the caution with which the surgical procedures were 
indicated. In the same manner, the time elapsed from the 
last CT to the surgical procedure was 8.7 [2–23] hours, 
somewhat large, but justified by the logistical difficulties, 
since this hospital is a teaching hospital with a very busy 
emergency department requiring surgery, and a wait-
ing list for the available operating rooms. Even without 
immediate availability of an operating room, the neuro-
surgery team remained in constant contact, evaluating 
and handling of these patients, which can be underlined 
by the time-elapsed hours between the last neurosur-
gery evaluation and the surgical procedure: up to 50% 
of the evaluated patients were subjected to surgery 
within 2,9 hours.
The median time of hospitalization, including the ICU 
and infirmary stay, was 21.5 [9.5–34.5] days. In a retrospec-
tive study carried out in France, where ten patients sub-
jected to DC were evaluated, the average ICU stay was 
22 days (3–58)22. It is important to highlight that the time 
of the present study was measured from the time of hospi-
talization to the final outcome, including one (5%) who was 
hospitalized for an elective tracheoplasty and fifteen days 
later suffered a stroke.
An average NIHSS score of 17.6 ± 3.2 was found upon 
hospitalization, which demonstrates the clinical sever-
ity of the patients. In a recent Japanese study involving 
355 patients, an average NIHSS score of 18 points (mini-
mum 0 – maximum 38) was shown at admission, and in 
the DC group it was 215. These results suggest that the 
patients in our study followed strict selection criteria for 
the surgical procedure.
A real limitation of this study is the type of outlining 
used, since the group of patients subjected to the DC proce-
dure was not compared to any other patients subjected to 
conservative treatment, as reported in the major random-
ized clinical trials7,8,9,12.
In conclusion, when performed based on a strict insti-
tutional protocol, DC is a great treatment option for the 
decrease of mortality and morbidity rates. 
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